PRG S&Tech develops therapeutic products for rare genetic disorders.
Founded in 2017 and based in Busan, South Korea, PRG S&Tech develops therapeutic products for rare genetic disorders and serves healthcare providers, research institutions, and pharmaceutical companies. In May 2026, it raised KRW 20 billion in pre-IPO funding from SL Investment, S Ventures, KDB Capital, K & Investment Partners, Sneak Peek Investment, J1 Venture Capital, Hanyang Securities, and Yuanta Securities Korea. Returning investors KNet Investment Partners, BNK Venture Capital, and Union Investment Partners also participated.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in